These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1632978

  • 21. Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patients.
    Kvinnsland S.
    Am J Clin Oncol; 1991; 14 Suppl 2():S46-51. PubMed ID: 1962597
    [Abstract] [Full Text] [Related]

  • 22. Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication.
    Modig H, Borgström S, Nilsson I, Westman G.
    J Steroid Biochem; 1990 Jun 22; 36(3):235-6. PubMed ID: 2142242
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of droloxifene and its metabolites in breast cancer patients.
    Grill HJ, Pollow K.
    Am J Clin Oncol; 1991 Jun 22; 14 Suppl 2():S21-9. PubMed ID: 1962593
    [Abstract] [Full Text] [Related]

  • 24. Pharmacologic and biologic properties of droloxifene, a new antiestrogen.
    Eppenberger U, Wosikowski K, Küng W.
    Am J Clin Oncol; 1991 Jun 22; 14 Suppl 2():S5-14. PubMed ID: 1962598
    [Abstract] [Full Text] [Related]

  • 25. Antiestrogen therapy for breast cancer: current strategies and future prospects.
    Jordan VC, Tormey DC.
    Cancer Treat Res; 1988 Jun 22; 39():97-110. PubMed ID: 2908611
    [Abstract] [Full Text] [Related]

  • 26. Trioxifene mesylate in the treatment of advanced breast cancer.
    Lee RW, Buzdar AU, Blumenschein GR, Hortobagyi GN.
    Cancer; 1986 Jan 01; 57(1):40-3. PubMed ID: 3940620
    [Abstract] [Full Text] [Related]

  • 27. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study.
    Valavaara R, Pyrhönen S, Heikkinen M, Rissanen P, Blanco G, Thölix E, Nordman E, Taskinen P, Holsti L, Hajba A.
    Eur J Cancer Clin Oncol; 1988 Apr 01; 24(4):785-90. PubMed ID: 2968265
    [Abstract] [Full Text] [Related]

  • 28. Phase III studies of toremifene in metastatic breast cancer.
    Pyrhönen SO.
    Breast Cancer Res Treat; 1990 Aug 01; 16 Suppl():S41-6. PubMed ID: 2149285
    [Abstract] [Full Text] [Related]

  • 29. Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communication.
    Ebbs SR, Roberts J, Baum M.
    J Steroid Biochem; 1990 Jun 22; 36(3):239. PubMed ID: 2142244
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Influence of droloxifene on metastatic breast cancer as first-line endocrine treatment.
    Haarstad H, Lønning PE, Gundersen S, Wist E, Raabe N, Kvinnsland S.
    Acta Oncol; 1998 Jun 22; 37(4):365-8. PubMed ID: 9743458
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
    Hoff PM, Valero V, Buzdar AU, Singletary SE, Theriault RL, Booser D, Asmar L, Frye D, McNeese MD, Hortobagyi GN.
    Cancer; 2000 May 01; 88(9):2054-60. PubMed ID: 10813717
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer.
    Howell A, DeFriend D, Robertson J, Blamey R, Walton P.
    Lancet; 1995 Jan 07; 345(8941):29-30. PubMed ID: 7799704
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Current status of toremifene, a new antiestrogenic agent for the treatment of breast cancer. A symposium. San Antonio, TX, USA, December 7, 1989.
    Breast Cancer Res Treat; 1990 Aug 07; 16 Suppl():S1-54. PubMed ID: 1980832
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.